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Abstract
Background: Influenza virus is a major cause of respiratory disease worldwide and Streptococcus pneumoniae
infection associated with influenza often leads to severe complications. Dendritic cells are key antigen presenting
cells but its role in such co-infection is unclear.
Methods: In this study, human monocyte derived-dentritic cells were either concurrently or successively
challenged with the combination of live influenza virus and heat killed pneumococcus to mimic the viral
pneumococcal infection. Dendritic cell viability, phenotypic maturation and cytokine production were then
examined.
Results: The challenge of influenza virus and pneumococcus altered dendritic cell functions dependent on the
time interval between the successive challenge of influenza virus and pneumococcus, as well as the doses of
pneumococcus. When dendritic cells were exposed to pneumococcus at 6 hr, but not 0 hr nor 24 hr after
influenza virus infection, both virus and pneumococcus treated dendritic cells had greater cell apoptosis and
expressed higher CD83 and CD86 than dendritic cells infected with influenza virus alone. Dendritic cells produced
pro-inflammatory cytokines: TNF-a, IL-12 and IFN-g synergistically to the successive viral and pneumococcal
challenge. Whereas prior influenza virus infection suppressed the IL-10 response independent of the timing of the
subsequent pneumococcal stimulation.
Conclusions: Our results demonstrated that successive challenge of dendritic cells with influenza virus and
pneumococcus resulted in synergistic up-regulation of pro-inflammatory cytokines with simultaneous down-
regulation of anti-inflammatory cytokine, which may explain the immuno-pathogenesis of this important co-
infection.
Background
Influenza virus is a major cause of respiratory disease
and bacterial infection associated with influenza often
increases morbidity and mortality [1,2]. Viral and bac-
terial co-infection is a common cause of death in seaso-
nal [3-8] and pandemic influenza [9-13]. Streptococcus
pneumoniae is the major bacterial pathogen associated
with influenza in 1918 Spanish pandemic [9,11-13]. In
the 2009 H1N1 pandemic, 29% of fatal cases of influ-
enza is reported to have evidence of bacterial co-infec-
tion, with Streptococcus pneumoniae is the predominant
type of pathogen identified [10]. Given the clinical
importance of this co-infection and the increasing risk
of influenza outbreak, it is important to understand how
the immune system would be affected in dealing with
the dual infection of these two pathogens.
Various studies have investigated the possible mechan-
isms of the co-infection in inducing disease severity
[14,15] and these can be classified into four broad cate-
gories, which are prior influenza infection would (i)
cause epithelial damage, (ii) increase pneumococcal
adherence, (iii) dysregulate immune system components
and (iv) enhance inflammatory response, such that the
effect of subsequent bacterial infection will be
exacerbated.
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Dendritic cells (DCs) are professional antigen present-
ing cells that are highly potent at initiating and regulat-
ing immune response to control infection. Co-infection
could alter innate cell responses [16] and different
populations of cell in the immune system have been stu-
died in the co-infection model of influenza virus and
pneumococcus [17-20]. Despite the critical role of DCs
in immune regulation, the response of DCs to this
important co-infection has not been reported yet. We
hypothesize that co-infection may alter DCs functions,
leading to the dysregulation of immune functions and
the elevated inflammatory response.
Pneumococcus is a human specific pathogen, however
most related studies on co-infection are conducted in
mouse model. It is demonstrated that human and mur-
ine DCs differ in their inflammatory response to pneu-
mococcus [21]. In light of this, we investigated the
immune response of human monocyte derived-dendritic
cells (MoDCs) to concurrent or successive challenge of
live influenza virus and heat killed S. pneumoniae to
mimic the co-infection. MoDC viability, phenotypic
maturation and cytokine production were examined. We
showed for the first time a time dependent pattern of
human MoDC functions alteration in response to vary-
ing dose of secondary pneumococcal challenge after
influenza virus infection, which is useful to help under-
stand the pathogenesis of this co-infection. This time
and dose related interaction of influenza virus and pneu-
mococcus in enhancing MoDCs pro-inflammatory cyto-
kines may be the first trigger for the enhanced lung
inflammation in patients with co-infection.
Methods
In vitro generation of MoDCs
Human peripheral blood was obtained from healthy
donors in accordance with an approved protocol from
the Institutional Review Board of The University of Hong
Kong/Hospital Authority Hong Kong West Cluster. Per-
ipheral blood mononuclear cells (PBMCs) were isolated
from whole blood samples by Ficoll-Paque Plus (GE
Healthcare Life Science) gradient centrifugation [22].
Monocytes were magnetically separated from PBMCs by
positive selection using anti-human CD14 conjugated
magnetic microbeads (Miltenyi Biotec). The purity of iso-
lated CD14+ cells was consistently > 90%, as determined
by flow cytometry. To generate human MoDCs, CD14+
monocytes were cultured in RPMI (Gibco BRL) supple-
mented with 10% FBS (Gibco BRL), 10 ng/ml IL-4
(Peprotech) and 50 ng/ml GMCSF (Peprotech) for 6
days, as we previously described [23]. The culture med-
ium was refreshed on day 3, and cell differentiation was
monitored using light microscopy. At day 6 of the cul-
ture, the purity of CD14-CD11c+ cells was consistently >
95%, as determined by flow cytometry.
Virus preparation, titration and infection
Human influenza virus A H1N1 (A/Hong Kong/54/98)
was cultured in Madin-Darby canine kidney cells
(American Type Culture Collection), as we described
[24,25]. Virus titer was determined by daily observation
of cytopathic effect, and the median tissue culture infec-
tive dose was calculated according to the Reed-Muench
formula. Immature MoDCs on day 6 of the culture were
washed before being infected with live H1N1 (strain
HK/54/98) at the indicated multiplicity of infection
(MOI). After 1 hr of viral adsorption, cells were washed
with excess PBS to remove unadsorbed virus.
Bacterial preparation, titration and stimulation
A clinical isolate of Streptococcus pneumoniae serotype
14 (strain 09M45278) recovered from blood sample of a
patient treated in a regional hospital in Hong Kong in
2009 was used. The pneumococcal isolate was stored at
-70°C. For recovery, an inoculated bead was directly
streaked onto 5% horse blood agar and grown 14 hrs at
37°C, 5% CO2. The colony growths were passaged onto
horse blood agars and grown for another 14 hrs at 37°C,
5% CO2. The colony growths from second pass were
harvested by picking to pre-warmed PBS at 37°C. Bac-
terial number was measured by OD absorbance at 600
nm, and bacterial counts (CFU/ml) were confirmed by
plating samples of 10-fold dilutions of bacteria on blood
agar plates. S. pneumoniae was heat killed by incubating
at 60°C for 1 hr as described [26]. Sterility was con-
firmed by subculture on blood agar plates. Prepared
pneumococcus was kept at 4°C and used within one
week. For every 1 × 106 immature or virus infected
MoDCs, cells were washed and challenged with heat
killed S. pneumoniae at 1 × 106, 5 × 106 or 10 × 106
CFU. Pneumococcus was added to MoDCs cultured in
24-well plate. The plate was centrifuged to achieve syn-
chronization of stimulation [27].
Viral bacterial stimulation protocol
MoDCs were challenged with the combination of live
influenza virus and heat killed pneumococcus either
concurrently or successively. In the concurrent chal-
lenge, MoDCs were first infected with H1N1 at MOI 0.1
for 0 hr, and then immediately stimulated with heat
killed pneumococcus at 1 × 106, 5 × 106 or 10 × 106
CFU for 24 hr. The total incubation time at harvest was
24 hr. As a control, MoDCs were infected with H1N1
alone or treated with pneumococcus alone for 24 hr. In
the successive challenge, MoDCs were first infected with
H1N1 at MOI 0.1 for either 6 hr or 24 hr, and then
treated with heat killed pneumococcus at 1 × 106, 5 ×
106 or 10 × 106 CFU for another 24 hr to make up a
total incubation time at harvest of 30 hr or 48 hr
respectively. As a control, for the 6 hr successive
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challenge group, MoDCs were infected with H1N1 alone
for 30 hr, or treated with pneumococcus alone for 24 hr.
For the 24 hr successive challenge group, MoDCs were
infected with H1N1 alone for 48 hr, or treated with
pneumococcus alone for 24 hr. In all the three groups
of viral bacterial challenge, MoDCs were mock treated
for 48 hr as negative control.
Cell staining and flow cytometry
For surface staining, MoDCs were washed and then
stained with APC conjugated anti-CD83 (HB15e), PE
conjugated anti-CD86 (IT2.2; both from BioLegend) and
FITC conjugated anti-HLA-DR, DP, DQ (Tu39; BD
Pharmingen) together in one tube. Cells incubated with
their relevant isotype controls were served as controls.
To avoid non-specific staining, cells were incubated in
PBS with 2 to 5% FBS during the staining process.
MoDC death was determined by PI staining in a sepa-
rate tube. MoDC apoptosis was determined using FITC
Annexin V apoptosis detection kit I (BD Pharmingen)
according to manufacturer’s instructions. All data were
acquired on BD FACSAria with FACS Diva (BD Bios-
ciences) and analyzed using FlowJo software (TreeStar)
as we described previously [28-30]. At least 15,000 gated
events were acquired per sample.
Quantification of cytokines by flowcytomix kits
The culture supernatant collected was assayed to deter-
mine cytokine concentration, including TNF-a, IL-6, IL-
12, IFN-g and IL-10 using FlowCytomix kits (Bender
MedSystems) according to manufacturer’s instructions.
Statistical analysis
Data are expressed as means ± standard deviation (SD).
Statistical analysis was performed by Repeated Measures
ANOVA with Bonferroni multiple comparison test
using Prism 4 (GraphPad Software). P value < 0.05 was
considered significant.
Results
MoDCs response to influenza virus infection
Influenza virus induces apoptosis of immune cells
[24,31,32]. We first investigated the dose response of
MoDCs to live influenza virus. Gating on the total
MoDC population at 24 hr after infection, an infectious
dose of MOI 0.05 induced CD86 and MHC-II expres-
sion significantly (Figure 1A, C). The percentage of PI+
MoDCs significantly increased at MOI 0.3 and reached
a plateau of almost 30% at MOI 1 (Figure 1D). Since
influenza virus infection at MOI 0.1 induced MoDC
maturation, yet without causing a considerable percen-
tage of cell death, MOI 0.1 was chosen to be the infec-
tious dose for the following experiments. As most
viruses are poor at replication once being internalized
by dendritic cells [33], we next investigated whether the
influenza virus infection of MoDCs was productive or
abortive. MoDCs were infected with H1N1 at MOI 0.1,
no infectious virus was detected in the culture superna-
tant collected at 0 hr, 6 hr, and 24 hr post-infection,
which indicated that the infection could not yield intact
virions (data not shown).
Successive challenge of influenza virus and
pneumococcus induced greater MoDC apoptosis
To examine cell survival, MoDCs were treated with
influenza virus, heat killed pneumococcus, or in combi-
nation of the two pathogens, and the cell apoptotic fre-
quency was examined by Annexin V and PI staining.
Influenza virus infection alone at MOI 0.1 mildly
increased the percentage of apoptotic cells (Figure 2A).
Heat killed pneumococcus at 1 × 106 CFU significantly
induced cell apoptosis, but increase of dose to 5 × 106
CFU and above had no effect in enhancing cell apopto-
sis (Figure 2B). In the viral bacterial challenge, when
MoDCs were treated with 5 × 106 CFU heat killed
pneumococci at 0 h or 6 hr after viral infection, the per-
centage of apoptotic cell was significantly higher than
that treated with virus alone or pneumococcus alone
(Figure 2C). However, when MoDCs were treated with
heat killed pneumococcus at 24 hr after viral infection,
the percentage of apoptotic cell was only significantly
higher than that treated with pneumococcus alone.
Figure 1 Response of MoDCs to influenza virus. MoDCs were
infected with influenza virus H1N1 (HK/54/98) at the indicated MOI.
24 hr after infection, cells were harvested and the surface
expressions of CD86, CD83 and MHC-II (A-C) were examined to
determine phenotypic maturation. Cells were stained with PI to
examine the percentage of dead cells after infection (D). Data (n =
4) represented mean ± SD of four individual experiments. Statistical
significance compared to MOI 0 *p < 0.05, **p < 0.01 (ANOVA).
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These results indicated that the induction of greater cell
apoptosis during the successive challenge was dependent
on the timing between the administration of influenza
virus and pneumococcus. Furthermore, the low dose of
pneumococcal stimulation alone was effective to induce
MoDC apoptosis, and there was a significant decreasing
trend of cell apoptosis upon the increasing dose of
pneumococcal stimulation (Figure 2B). However, this
dose dependent effect was abolished when pneumococ-
cal stimulation was preceded by influenza virus infection
(Figure 2D, comparing the loss of significant trend of
white column with black column).
Successive challenge of influenza virus and
pneumococcus caused a time related change in MoDC
phenotype
Maturation is an important process for dendritic cell to
exercise its function. Gating on the viable population of
MoDCs after pathogen stimulation, MoDCs were phe-
notypically activated by either influenza virus or heat
killed pneumococcus (Figure 3A). In viral bacterial chal-
lenge, when MoDCs were treated with 5 × 106 CFU
heat killed pneumococci at 0 hr or 6 hr after virus infec-
tion, the expression of CD83 was comparable to that in
pneumococcal stimulated MoDCs, but it was signifi-
cantly higher than that in virus infected MoDCs (Figure
3B). This suggested that pneumococcus tended to be
the major contributor for the up-regulation of CD83.
When compared to the influenza virus infection alone,
MoDCs became more mature by the secondary pneu-
mococcal challenge. When MoDCs were treated with 5
× 106 CFU heat killed pneumococci at 6 hr after virus
infection, the expression of CD86 was significantly
higher than that infected with influenza virus alone (Fig-
ure 3C). However, in all the conditions of the viral bac-
terial challenge performed, MoDCs treated with both
the two pathogens expressed comparable level of MHC-
II to that infected with virus alone or treated with pneu-
mococcus alone (Figure 3D). Furthermore increase in
secondary pneumococcal dose after influenza virus
infection did not change the expression of CD83, CD86
and MHC-II on MoDCs treated with both the two
pathogen significantly (data not shown).
Successive challenge of influenza virus and
pneumococcus dysregulated MoDC cytokine production
Another important function of mature dendritic cell is
to produce cytokines to regulate immune response
against pathogens. We investigated the induction of
pro-inflammatory cytokines: TNF-a, IL-6, IL-12 and
IFN-g, as well as anti-inflammatory cytokine: IL-10 by
FlowCytomix Multiplex following pathogens stimulation.
MoDCs produced IL-6, IFN-g, TNF-a, IL-12 and IL10
after single heat killed pneumococcal challenge. Increase
in pneumococcal dose from 1 × 106 to 10 × 106 CFU,
MoDCs gradually produced more IL-10 with a significant
increasing trend, and less TNF-a and IL-12 with a signifi-
cant decreasing trend (Figure 4A). Influenza virus infec-
tion alone at MOI 0.1 mildly induced TNF-a, IL-6 and
IFN-g from MoDCs (Figure 4B). The secretions of IL-12
Figure 2 MoDC apoptosis induced by successive challenge of
influenza virus and pneumococcus. (A) MoDCs were infected with
H1N1 at MOI 0.1. The percentage of apoptotic cells was examined at 24
hr, 30 hr or 48 hr after virus infection. (B) MoDCs were treated with heat
killed pneumococcus at 1 × 106, 5 × 106 or 10 × 106 CFU. The percentage
of apoptotic cells was examined at 24 hr after pneumococcal stimulation.
(C-D) MoDCs were concurrently or successively challenged by both
influenza virus and heat killed pneumococcus. (C) MoDCs were first
infected with H1N1 at MOI 0.1 for 0 hr, and then immediately treated
with 5 × 106 CFU heat killed pneumococcus for another 24 hr. The total
incubation time at harvest was 24 hr. Alternatively, MoDCs were first
infected with H1N1 at MOI 0.1 for 6 hr or 24 hr, and then treated with 5 ×
106 CFU heat killed pneumococcus for another 24 hr to make up a total
incubation time at harvest of 30 hr or 48 hr respectively. (D) MoDCs were
infected with H1N1 at MOI 0.1 for 6 hr, and then treated with 1 × 106, 5 ×
106 or 10 × 106 CFU heat killed pneumococcus for another 24 hr, with a
total incubation time at harvest was 30 hr. Data (n = 6) represented mean
± SD of five individual experiments. Please note that some groups of data
were presented twice in different panels for easy interpretation. *p < 0.05,
**p < 0.01, ***p < 0.001 (ANOVA) and ##p < 0.01 (Post test for trend).
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and IL-10 from virus infected MoDCs were lower than the
detectable limitation (data not shown). The lack of IL-12
and IL-10 response was consistent with DNA microarray
study that gene expression of IL-12p40 and IL-10 from
human MoDCs was unchanged in response to influenza
virus [34], and myeloid DCs produced no IL-10 upon
TLR3 agonist polyIC stimulation [35].
In the viral bacterial challenge, the regulation of pro-
inflammatory cytokine could be synergistic or non-
synergistic. First, a synergistic production of TNF-a
(Figure 5A), IFN-g (Figure 5B) or IL-12 (Figure 5C) was
observed when MoDCs were stimulated with heat killed
pneumococcus at 6 hr, but not 0 hr nor 24 hr after
virus infection. This demonstrated that the time
between the consecutive viral bacterial challenges was a
critical factor to regulate the inflammatory response. In
the 6 hr successive challenge group, when the viral bac-
terial synergism occurred, increase in the dose of sec-
ondary pneumococcus promoted a stronger production
of TNF-a (Figure 5D), IFN-g (Figure 5E) or IL-12 (Fig-
ure 5F). These results indicated that successive challenge
of influenza virus and pneumococcus induced a time
and dose dependent synergism in the production of pro-
inflammatory cytokines. Furthermore, in the regulation
of TNF-a, increasing dose of heat killed pneumococcus
alone from 1 × 106 to 10 × 106 CFU resulted in a signif-
icant decreasing trend of TNF-a production. However,
this decreasing trend was reversed to that of a signifi-
cant increasing trend of TNF-a production when the
pneumococcal stimulation was preceded by influenza
virus infection (Figure 5D, compare the significant trend
of white column with black column). Taken together,
Figure 3 MoDCs phenotype expression induced by successive challenge of influenza virus and pneumococcus. (A) MoDCs were infected
with H1N1 at MOI 0.1 or treated with heat killed pneumococcus at 1 × 106, 5 × 106 or 10 × 106 CFU. Cell phenotypic maturation was examined
at 24 hr, 30 hr or 48 hr after virus infection, or at 24 hr after pneumococcal stimulation. (B-D) MoDCs were concurrently or successively
challenged by both influenza virus and heat killed pneumococcus. MoDCs were first infected with H1N1 at MOI 0.1 for 0 hr, and then
immediately treated with 5 × 106 CFU heat killed pneumococcus for another 24 hr. The total incubation time at harvest was 24 hr. Alternatively,
MoDCs were first infected with H1N1 at MOI 0.1 for 6 hr or 24 hr, and then treated with 5 × 106 CFU heat killed pneumococcus for another 24
hr to make up a total incubation time at harvest of 30 hr or 48 hr respectively. Data (n = 5-7) represented mean ± SD of six individual
experiments. Please note that some groups of data were presented twice in different panels for easy interpretation. *p < 0.05, **p < 0.01, ***p <
0.001 (ANOVA) and ###p < 0.001 (Post test for trend).
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these data suggested that successive challenge of influ-
enza virus and pneumococcus on MoDCs generally pro-
moted inflammatory response.
Second, in the 24 hr successive challenge group, when
the viral bacterial synergism was absent, the dose of
pneumococcus became another important factor to reg-
ulate the inflammatory response. Beginning with a low
dose (1 × 106 CFU) of heat killed pneumococcal stimu-
lation after virus infection, MoDCs produced signifi-
cantly lower amount of TNF-a (Figure 5G) and IL-6
(Figure 5H) than that treated with pneumococcus alone.
While the dose of secondary pneumococcus increased
to 5 × 106 and 10 × 106 CFU, the production of TNF-a
increased and eventually became significantly higher
than that treated with pneumococcus alone (Figure 5G).
Similarly the reduced production of IL-6 was rescued
with the increasing dose of pneumococcus (Figure 5H).
This demonstrated a competition between influenza
virus and pneumococcus during the successive chal-
lenge, with the virus infection tended to lower pro-
inflammatory cytokines secretion, whereas the increasing
pneumococcal stimulation tended to promote inflamma-
tory response.
In the regulation of anti-inflammatory cytokine, a
negative antagonistic interaction of influenza virus and
pneumococcus was observed in the induction of IL-10.
While MoDCs produced IL-10 significantly after heat
killed pneumococcal stimulation at 5 × 106 CFU, the IL-
10 induced by pneumococcus alone was significantly
inhibited when pneumococcal stimulation was preceded
by influenza virus infection (Figure 6A). The inhibition
of IL-10 was independent of the time intervals between
the successive viral and pneumococcal challenge (Figure
6A). Furthermore, with the dose of secondary pneumo-
coccus increase to 10 × 106 CFU, the inhibition of IL-10
by prior influenza virus infection remained significant
(Figure 6B).
Taken together, the interaction of influenza virus and
pneumococcus in the regulation of MoDC cytokine pro-
duction was complex with both time and dose depen-
dency. There were synergistic induction of pro-
inflammatory cytokines and significant suppression of
anti-inflammatory cytokine, which was dependent on
the different permutations of the time intervals between
the challenge of the two pathogens and pneumococcal
dose.
Figure 4 MoDC cytokine profile in response to influenza virus or pneumococcus. (A) MoDCs were treated with 1 × 106, 5 × 106 or 10 ×
106 CFU heat killed pneumococcus for 24 hr or (B) infected with H1N1 at MOI 0.1 for 0 hr, 24 hr, 30 hr or 48 hr. The concentration of cytokine
in culture supernatant was determined. Data (n = 5-7) represented mean ± SD of six individual experiments. **p < 0.01 (ANOVA) and #p < 0.05,
###p < 0.001 (Post test for trend).
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Figure 5 MoDC pro-inflammatory cytokines in response to successive challenge of influenza virus and pneumococcus. (A-H) MoDCs
were concurrently or successively challenged by both influenza virus and heat killed pneumococcus. (A-C) MoDCs were infected with H1N1 at
MOI 0.1 for 0 hr, 6 hr or 24 hr, and then treated with 5 × 106 CFU heat killed pneumococcus for another 24 hr to make up a total incubation
time at harvest of 24 hr, 30 hr or 48 hr respectively. (D-F) MoDCs were infected with H1N1 at MOI 0.1 for 6 hr, and then treated with 1 × 106, 5
× 106 or 10 × 106 CFU heat killed pneumococcus for another 24 hr, with a total incubation time at harvest was 30 hr (G-H) MoDCs were first
infected with H1N1 at MOI 0.1 for 24 hr, and then treated with 1 × 106, 5 × 106 or 10 × 106 CFU heat killed pneumococcus for another 24 hr,
with a total incubation time at harvest was 48 hr. Data (n = 5-7) represented mean ± SD for six individual experiments. Please note that some
groups of data were presented twice in different panels for easy interpretation. *p < 0.05, **p < 0.01, ***p < 0.001 (ANOVA), post test for trend
between white columns #p < 0.05 and black columns ^^ p < 0.01.
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Discussion
Influenza virus co-infection with pneumococcus often
leads to severe complications [1,2,14,15]. The present
study addressed the dysregulation of MoDCs to viral
bacterial challenge and provided direct descriptions of
how human myeloid DCs respond to the two human
pathogens. The major finding was that successive chal-
lenge of influenza virus and pneumococcus resulted in
time and dose dependent changes in MoDC functions
which promoted inflammation.
Viral bacterial co-infection accounts for substantial ill-
ness and death in seasonal and pandemic influenza [3-13].
Such co-infection can be either mixed viral bacterial infec-
tion with two pathogens at the beginning or sequential
infection with pneumococcus usually comes in 5 to 7 days
after viral infection. We mimic the viral bacterial co-infec-
tion and treat MoDCs with three different doses of pneu-
mococcus at three different time points after the initial
influenza virus infection. This allows us to capture the
dynamic changes of MoDC response to these nine differ-
ent permutations of time and dose related challenging.
First we demonstrated a general characteristic of
MoDCs during the successive viral bacterial challenging,
in which comprised of up-regulation of pro-inflammatory
cytokines and down-regulation of anti-inflammatory cyto-
kine. This finding suggested the possible contribution of
dendritic cell to the inflammatory response in co-infection.
Successive challenge of influenza and pneumococcus
enhanced pro-inflammatory cytokines from MoDCs,
which could potentially explain the human autopsy mate-
rial from victim in 1918 Spanish flu showed the lung
pathology of bacterial bronchopneumonia with intense
inflammation [36,37], and the animal data with elevated
lung inflammatory cytokines, as well as greater destruction
of lung architecture during the co-infection [18,38].
Second, we demonstrated successive challenge of influ-
enza virus and pneumococcus increased MoDCs apoptosis.
The underlying mechanism of the increased MoDC apop-
tosis is not clear. A previous study indicated that autocrine
IL-10 from BMDCs upon heat killed pneumococcal stimu-
lation was crucial for delaying the onset of BMDC apopto-
sis [26]. Here, we also found that a high dose of heat killed
pneumococcus alone induced IL-10 from MoDCs (Figure
4A) and did not cause significant cell apoptosis (Figure 2B),
while prior influenza virus infection of MoDCs inhibited
the IL-10 induced by pneumococcus (Figure 6) and
increased cell apoptosis (Figure 2C). These results suggest
that the reduced survival of MoDCs may be related to the
decreased IL-10 response in MoDCs during the successive
challenge of virus and pneumococcus.
Apoptotic DCs have low efficiency for T cell priming
and are ineffective at inducing immunity. The enhanced
MoDC apoptosis from successive challenge might enhance
disease severity of viral bacterial co-infection. For the 6 hr
successive challenge group, there were both marked up-
regulation of cell apoptosis and pro-inflammatory cytokine
production. Apoptosis could be a strategy for the resolu-
tion of inflammatory response [39]. Alveolar neutrophil
apoptosis has been suggested to help down-regulating
lung inflammation in patients with community acquired
pneumonia [40]. However, there is no report describing
the possible relationship between inflammation and apop-
tosis on dendritic cells. On the other hand, acute inflam-
matory response could lead to cell apoptosis [41], and the
Figure 6 MoDC anti-inflammatory cytokine in response to successive challenge of influenza virus and pneumococcus. MoDCs were
concurrently or successively challenged by both influenza virus and heat killed pneumococcus. (A) MoDCs were first infected with H1N1 at MOI
0.1 for 0 hr, 6 hr or 24 hr, and then treated with 5 × 106 CFU heat killed pneumococcus for another 24 hr to make up a total incubation time at
harvest of 24 hr, 30 hr or 48 hr respectively. (B) MoDCs were first infected with H1N1 at MOI 0.1 for 6 hr, and then treated with 1 × 106, 5 × 106
or 10 × 106 CFU heat killed pneumococcus for another 24 hr, with a total incubation time at harvest was 30 hr. Data (n = 5-7) represented
mean ± SD for six individual experiments. Please note that some groups of data were presented twice in different panels for easy interpretation.
*p < 0.05 (ANOVA).
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dying cells might in turn alert immune system to become
activated [42]. In vivo, TNF-a was reported to block apop-
totic cell clearance by alveolar macrophages, and exacer-
bated inflammatory response in the lung [43]. Our
findings suggested that inflammation and cell death might
interact with each other and contributed to the severe
lung injury in co-infection.
Third, we found that influenza virus and pneumococ-
cus synergistically or non-synergistically dysregulated
MoDC cytokine response. In the synergistic regulation,
virus and pneumococcus worked together to alter
MoDC functions. This was observed when cell were sti-
mulated with high dose of pneumococcus at 6 hr, but
not 0 h nor 24 hr after the influenza virus infection.
Our data clearly revealed that the viral bacterial syner-
gism might only occur when secondary pneumococcus
was introduced during the critical time period. These
findings are consistent with mouse study showing a
time and dose related synergistic lethality of influenza
virus and pneumococcus [19], in which the greatest
mortality of sequential infection occured when second-
ary pneumococal infection comes at 7 days, but not 0 to
3 days nor 14 to 21 days after influenza virus infection.
The window period for the second challenge will of
course be different between in vitro and in vivo study.
The critical window period in altering MoDC functional
changes suggested that there could be different critical
time window for mixed and sequential viral bacterial
infection. The role of the time interval between influ-
enza virus infection and pneumococcal challenge in dys-
regulating MoDC functions is consistent with the
suggested importance of the timing in two successive
infections on the magnitude of inflammation [16].
On the other hand, in certain permutation of time
intervals and pneumococcal doses, when the viral bac-
terial synergism was absent, the dose of pneumococcus
was the determining factor to change MoDC response.
For instance, with a low dose of pneumococcus, the pre-
ceding virus infection appeared to be determinative in
skewing the MoDC cytokine production towards sup-
pression of TNF-a, IL-6 and IL-10 as stimulated by the
bacteria. In contrast, with the increasing dose of pneu-
mococcus, the bacteria gradually dominated its effect
over influenza virus, and turned the MoDC cytokine
production towards up-regulation of pro-inflammatory
cytokines: TNF-a, IFN-g, IL-12 and IL-6.
Collectively, our data indicated that MoDC response
to pathogen challenge is very plastic, dependent on the
combination of time interval between the challenges of
the two pathogens as well as the dose of the pathogens.
This agrees with the study showing that human MoDCs
can elicit both shared core and tailored pathogen speci-
fic immune response [34]. However, the present findings
are limited to in vitro study, and future in vivo
experiments would help better understand how the
innate immune cells may differentially respond to the
co-infection. In additions, the underlying mechanisms
that integrate the different signals delivered by the influ-
enza virus infection and pneumococcal challenge result-
ing in the observed cell response remain to be
elucidated. Furthermore, the infective environment in
which DCs are conditioned can influence the way they
control and regulate subsequent T cell response [44]. As
our findings demonstrated that successive challenge of
MoDCs with influenza virus and pneumococcus up-
regulated IL-12 and IFN-g, which could skew developing
immune responses toward Th1, we shall further investi-
gate the regulation of adaptive immunity to co-infection.
Conclusions
In summary, successive challenge of influenza virus and
pneumococcus favour the production of pro-inflamma-
tory cytokines and suppression of anti-inflammatory
cytokine from human MoDCs, which are both time
interval and pneumococcal dose dependent, reflecting
the plasticity of dendritic cell to combination of patho-
gens. Our study contributes to the understanding of the
underlying pathogenesis of severe bacterial infection
associated with influenza.
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